🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06703307
Recruiting Observational

Biomarkers Related to PSCI: An fNIRS Study

NCT06703307 · tracked via the Priya Life Science China tracker
Sponsor
Dingqun Bai
Phase
Observational
Started
2024-08-01
Last updated
2024-11-26

Condition(s) studied

StrokeCognitive Decline

Study summary

This is an fNIRS study performed to identify biomarkers related to post-stroke cognitive impairment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: Stroke patients: 1. Diagnosis of stroke confirmed by neuroimaging (CT or MRI) 2. 18-80 years old 3. Able to complete the cognitive task 4. Able to follow instructions to complete the trial 5. Patients who signed an informed consent form. Healthy Subjects: 1. No abnormalities on cranial 2. 18-80 years old 3. Able to complete cognitive task 4. Able to follow instructions to complete the trial 5. not taking medications. 6. Subjects who signed an informed consent form. Exclusion Criteria: Stroke patients: 1. Inability to tolerate the test due to organic diseases 2. Serious mental illness that prevents them from cooperating with or tolerating the trial 3. Pregnant or lactating women 4. Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction. Healthy Subjects: 1. Inability to tolerate the test due to organic diseases 2. Serious mental illness that prevents them from cooperating with or tolerating the trial. 3. Pregnant or lactating women 4. Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Rehabilitation Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Chongqing Municipality Recruiting

More Dingqun Bai trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06703307 on ClinicalTrials.gov ↗ ← All trials in China